Announcements

Announcements

Bill & Melinda Gates Medical Research Institute    [to 14 April 2018]
https://www.linkedin.com/company/bill-melinda-gates-medical-research-institute/
   The Bill & Melinda Gates Medical Research Institute is a non-profit research organization dedicated to combating diseases that impact the world’s poorest. We strive to combat inequities in health by accelerating progress in translational science to ensure life-saving products are available and accessible to everyone. We consider ourselves pioneers dedicated to uncovering radical solutions that will close the gap between cutting-edge scientific innovation and its application to challenges in global health.
No new digest content identified.

 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 14 April 2018]
http://cepi.net/
Posted on 11TH APR 2018 by Rachel Grant
Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS
Major investment by Coalition for Epidemic Preparedness Innovations (CEPI) to advance vaccine development and manufacturing on two of CEPI’s highest priority infectious diseases
[See Milestones/Perspectives above for more detail]

IVAC  [to 14 April 2018]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
IVAC Blog
IVAC Welcomes Dr. Naor Bar-Zeev
Posted 4/10/18
The International Vaccine Access Center (IVAC) is pleased to announce that Naor Bar-Zeev, MBBS(Hons), MPH, MBiostat, PhD, has joined the IVAC team as an Associate Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

 
MSF/Médecins Sans Frontières  [to 14 April 2018]
http://www.doctorswithoutborders.org/news-stories/press/press-releases
April 13, 2018
Central African Republic: MSF Treats Wounded Amid Violence in Bangui
MSF has treated 80 wounded patients amid violence in Bangui over the past week. In the early morning of April 8, United Nations and Central African Republic security forces launched a joint operation in the PK5 neighborhood in Bangui, which involved heavy fighting and resulted in dozens of people injured.

Press release
Syria: Displaced People From Eastern Ghouta Need Treatment
April 13, 2018
Roughly 60,000 people have been displaced from eastern Ghouta, near Damascus, to northwestern Syria in the past month. A significant number of these men, women, and children are injured or sick and in need of medical care. Doctors Without Borders/Médecins Sans Frontières (MSF) supports the main hospital in charge of triaging and treating these patients at a location known as the “zero point,” where people arrive on buses.

 
NIH  [to 14 April 2018]
http://www.nih.gov/news-events/news-releases
April 9, 2018
NIH scientists develop macaque model to study Crimean-Congo hemorrhagic fever
— CCHF is a viral disease spread by ticks in the Middle East, Asia, Africa and parts of Europe.
 
 
PATH  [to 14 April 2018]
http://www.path.org/news/index.php
Press release | April 12, 2018
New study results from Uganda strengthen the case for contraceptive self-injection
Study finds that self-administration enables women to use injectable contraception longer

Announcement | April 10, 2018
PATH names Anthony Okoth as Country Director for Kenya office

UNICEF  [to 14 April 2018]
https://www.unicef.org/media/
Selected Press Releases
11 April, 2018
WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally
GENEVA – The World Health Organization (WHO) and UNICEF today issued new ten-step guidance to increase support for breastfeeding in health facilities that provide maternity and newborn services. Breastfeeding all babies for the first two years would save the lives of more than 820,000 children under age 5 annually.

Nearly one billion people in Africa to be protected against yellow fever by 2026
ABUJA, 10 April 2018 — Nearly one billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from the World Health Organization (WHO), Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners.
[See Milestones/Perspectives above for more detail]

High risk of disease outbreaks in earthquake-hit Papua New Guinea – UNICEF and WHO
PORT MORESBY, 9 April 2018 – UNICEF and the World Health Organization (WHO) have cautioned about the high potential of waterborne and vaccine-preventable disease outbreaks in earthquake-affected areas of Papua New Guinea.
 

Wellcome Trust  [to 14 April 2018]
https://wellcome.ac.uk/news
Published: 12 April 2018
How to make sense of the brain’s billions of neurons
A unique global collaboration is attempting to transform the way we study the brain. If it succeeds, it could start to address longstanding unanswered questions about how brain disorders alter our neural circuits.

Genetic changes linked to adult kidney cancer can occur in childhood
News / Published: 12 April 2018
Researchers at the Wellcome Sanger Institute have discovered that key genetic changes which may lead to kidney cancer can occur as early as childhood or adolescence. This can be up to 50 years before the disease is diagnosed

How we’ve defined what success looks like for Wellcome’s work
Explainer / Published: 10 April 2018
Chonnettia Jones, our Director of Insight and Analysis, explains how developing a success framework is leading to new ways of thinking and working across Wellcome

 
The Wistar Institute   [to 14 April 2018]
https://www.wistar.org/news/press-releases
Press Release   Apr. 12 2018
Novel Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
Co-targeting BET and MEK holds promise as a salvage therapy for melanoma resistant to targeted therapy and immunotherapy.

::::::
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 14 April 2018]
http://www.dcvmn.org/
14 April 2018
Regional workshop: Optimization of vaccines’ manufacturing, containers and testing for global supply
7 May 2018 to 10 May 2018
Hyderabad / India
 
 
Industry Watch    [to 14 April 2018]
:: Boehringer Ingelheim to invest €65 million in avian vaccines
Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Porte-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian vaccines
The Group has thus confirmed its commitment to making France, and Lyon in particular, one of its major growth drivers in the animal health market
April 11, 2018